Cellicon Valley '25: The Future of Cell and Gene Therapies

Penn Medicine and Children's Hospital of Philadelphia remain at the forefront of cell and gene therapy, solidifying Philadelphia's status as "Cellicon Valley." The University of Pennsylvania continues to lead in CAR-T cell research, reflecting its ongoing commitment to innovation in this field, particularly through the pioneering work of the Center for Cellular Immunotherapies . While CAR T-cell therapy has already revolutionized cancer treatment, the field continues to evolve rapidly.